Key facts
- Adtec Healthcare’s last known valuation is $18.3M (Jul 2025).
- It has raised $11.9M; the latest was PE Growth/Expansion ($11.9M) in Jul 2025.
- Notable investors include AIPO Fund, SG Biomedical.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Adtec Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for Adtec Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Adtec Healthcare
Developer of cold plasma medical devices designed to treat chronic wounds and antimicrobial-resistant infections in clinical settings across Europe and Asia. The company provides infection control, dermatology services, and surgical support technologies, thereby enabling hospitals and clinics to improve patient recovery outcomes and manage antimicrobial resistance more effectively.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 10
- Website
- adtechealthcare.com/
- Ownership
- Privately Held (backing)
Adtec Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adtec Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adtec Healthcare in its N-PORT filings yet. We sweep new filings monthly.